Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Lymph Node Mapping Using Indocyanine Green Solution in Diagnosing Patients With Malignant Melanoma [NA]
Stanford-sponsored trial evaluated lymph node mapping using indocyanine green in patients with recurrent melanoma. The study is completed an…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: mRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma [Phase 2]
Phase 2 trial evaluating mRNA-electroporated autologous dendritic cells for stage III/IV melanoma has completed.
-
CLINICAL_TRIALS withdrawal · 2017-05-24Clinical Trial Update: Radiation Use During Vemurafenib Treatment [Phase 1]
A Phase I trial investigating the use of radiation during vemurafenib treatment for BRAFV600 mutation-associated Stage IV melanoma has been …
-
CLINICAL_TRIALS research · 2017-05-24Clinical Trial Update: Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.
A completed study that collects blood samples from patients with melanoma, breast cancer, lung cancer, pancreatic cancer, and colorectal can…
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Biomarkers to Predict Response to Interferon Therapy in Patients With Melanoma
A clinical trial update reports on biomarkers that may predict which melanoma patients respond to interferon therapy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Biomarkers in Patients With High-Risk Melanoma Receiving High-Dose Interferon Therapy
Biomarker findings from a completed trial of high-dose interferon therapy in patients with high-risk melanoma are reported.
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Tissue and Blood Biomarkers From Patients With Stage III or Stage IV Melanoma Treated With Ipilimumab With or Without Sargramostim
This trial update summarizes tissue and blood biomarker analyses from patients with stage III/IV melanoma treated with ipilimumab, with or w…
-
CLINICAL_TRIALS research · 2017-05-17Clinical Trial Update: Study of Tumor Tissue From Patients With Melanoma Treated on Clinical Trial EST-1690
This entry describes a completed investigation that analyzes tumor tissue from patients with melanoma who were treated on clinical trial EST…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate
Completed clinical trial assessing biomarkers to predict response to chemotherapy (carboplatin and paclitaxel) with or without sorafenib in …
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With Sargramostim
This completed clinical trial investigated biomarkers in blood from patients with stage IV melanoma who had prior treatment with sargramosti…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064) [Phase 2]
Phase 2 study evaluating temozolomide for brain metastases from melanoma, breast cancer, or non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Bevacizumab Combined With Carboplatin Plus Paclitaxel Chemotherapy to Treat Metastatic Mucosal Melanoma [Phase 2]
A Phase 2 clinical trial is evaluating bevacizumab in combination with carboplatin and paclitaxel for metastatic mucosal melanoma.
-
CLINICAL_TRIALS research · 2017-05-03Clinical Trial Update: Buparlisib in Melanoma Patients Suffering From Brain Metastases (BUMPER) [Phase 2]
Phase 2 clinical trial update for buparlisib in melanoma patients with brain metastases (BUMPER). The current status of the trial is UNKNOWN…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: FLuorescence Identification of Melanoma by a Multicenter Based Algorithm (FLIMMA)
A completed multicenter clinical trial evaluating fluorescence-based identification of melanoma using the FLIMMA algorithm.
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets Pts [NA]
A completed clinical trial evaluated combining ipilimumab with lymphodepletion, adoptive cell transfer, and high-dose interleukin-2 in metas…
-
CLINICAL_TRIALS research · 2017-05-02Clinical Trial Update: New Tumor Models in Three Dimensions and in a Human Skin Environment for Personalized Melanoma Therapy [NA]
This update describes the development of three-dimensional tumor models in a human skin environment for personalized melanoma therapy. It re…
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Digital vs. Printed Photographs: Impact on Skin Self-Examinations [NA]
A completed study from the University of Pennsylvania evaluated the impact of digital versus printed photographs on how people perform skin …
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma [Phase 1]
Phase 1 trial evaluating the combination of ipilimumab (Yervoy) and pegylated interferon alfa-2b (Sylatron) in unresectable stage III/IV mel…
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: Study of Autoimmune Disease Complications Following Ipilimumab Treatment Among Melanoma Patients With Underlying Autoimmune Diseases
This completed trial assesses autoimmune disease complications and safety of ipilimumab in melanoma patients with pre-existing autoimmune di…
-
CLINICAL_TRIALS research · 2017-04-27Clinical Trial Update: Early Therapy Response Monitoring in Melanoma Patients Using PET/MRI [NA]
An update on a clinical trial investigating early therapy response monitoring in melanoma patients using PET/MRI. The trial status is curren…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: CTLA-4 Blockade and Low Dose Cyclophosphamide in Patients With Advanced Malignant Melanoma [Phase 2]
Phase 2 trial evaluating CTLA-4 blockade in combination with low-dose cyclophosphamide for advanced melanoma has been terminated. Results fr…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Study of ADI-PEG 20 in Patients With Advanced Melanoma [Phase 1, Phase 2]
Phase 1/2 clinical trial of ADI-PEG 20 in advanced melanoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Trial of ABI-007 in Previously Treated Patients With Metastatic Melanoma [Phase 2]
A Phase 2 trial evaluating ABI-007 (nab-paclitaxel) in previously treated patients with metastatic melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma [Phase 1, Phase 2]
The completed Phase 1/2 trial evaluated the combination of laboratory-treated T cells with ipilimumab in patients with metastatic melanoma. …
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study [Phase 1]
Phase 1 feasibility study evaluating PV-10 in melanoma with a focus on immune cell infiltration has completed.